Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/3/2025 | Overweight → Sector Weight | KeyBanc Capital Markets | |
| 10/2/2025 | $70.00 | Buy → Neutral | Citigroup |
| 10/2/2025 | $67.00 | Neutral → Overweight | Analyst |
| 8/13/2025 | $84.00 | Equal Weight → Overweight | Barclays |
| 3/31/2025 | $69.00 | Hold → Buy | Argus |
| 3/13/2025 | $71.00 | Buy | Goldman |
| 10/23/2024 | $68.00 | Buy | Citigroup |
| 10/16/2024 | $59.00 → $67.00 | Neutral → Buy | BofA Securities |
Partnership will leverage Corteva technology and bp integrated downstream capabilities to produce and deliver biofuel feedstocks to global markets Ignacio Conti to be CEO, Gaurav Sonar to be Chair of the Board of Directors INDIANAPOLIS and LONDON, Jan. 7, 2026 /PRNewswire/ -- Corteva Inc. (NYSE:CTVA) and bp (NYSE:BP, LSE: BP.L)) today announced the launch of Etlas, their new 50:50 joint venture that will produce oil from crops – including canola, mustard and sunflower – for use in the production of biofuels like sustainable (or synthetic) aviation fuel (SAF) and renewable diesel (RD). Etlas will harness both Corteva's century-long expertise in seed technology to develop crops ideally suited
INDIANAPOLIS, Jan. 6, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE:CTVA) today announced it will release its fourth quarter 2025 earnings on Tuesday, February 3, 2026, after the stock market close via press release and its website. The earnings will be presented in a live webcast on Wednesday, February 4, 2026, at 9:00 a.m. Eastern Time. The slide presentation that accompanies the webcast will be posted on the Company's Investor Events and Presentations page. A replay of the webcast will be available on the Investor Events and Presentations page until February 4, 2027. About Corte
Landmark Agreement is First Ag-Pharma Collaboration for Both Companies Corteva (NYSE:CTVA), a global leader in agricultural technology, and Hexagon Bio, a biotechnology company pioneering a new way to discover nature-derived medicine, today announced a multi-million-dollar joint venture (JV) to accelerate the development of new crop protection solutions inspired by nature. The JV is the first in the agriculture sector for Hexagon Bio and the first in the pharmaceutical industry for Corteva. The partnership brings together Corteva's billion-dollar nature-inspired crop protection franchises and bacterial natural product discovery capabilities with Hexagon Bio's natural-product discovery pla
KeyBanc Capital Markets downgraded Corteva from Overweight to Sector Weight
Citigroup downgraded Corteva from Buy to Neutral and set a new price target of $70.00
Analyst upgraded Corteva from Neutral to Overweight and set a new price target of $67.00
4 - Corteva, Inc. (0001755672) (Issuer)
4 - Corteva, Inc. (0001755672) (Issuer)
4 - Corteva, Inc. (0001755672) (Issuer)
4 - Corteva, Inc. (0001755672) (Issuer)
4 - Corteva, Inc. (0001755672) (Issuer)
4 - Corteva, Inc. (0001755672) (Issuer)
SCHEDULE 13G - Corteva, Inc. (0001755672) (Subject)
10-Q - Corteva, Inc. (0001755672) (Filer)
8-K - Corteva, Inc. (0001755672) (Filer)
Cornel Fuerer to remain corporate secretary, transition to strategic advisor before retiring in 2026 INDIANAPOLIS, Aug. 26, 2025 /PRNewswire/ -- Corteva, Inc. (NYSE:CTVA) announced today that it has appointed Jennifer Johnson as its new chief legal officer, effective September 15, 2025. As such, she will oversee the company's global legal function and will join the company's executive leadership team (ELT). She will succeed Cornel Fuerer, the company's current chief legal and public affairs officer and corporate secretary, who will retain oversight for the public affairs function and continue as corporate secretary, transitioning these responsibilities to Johnson at the end of 2025. Fuerer w
Seasoned SaaS and Artificial Intelligence (AI) veteran joins Siteimprove to drive the next phase ofinnovation and growth BELLEVUE, Wash. and COPENHAGEN, Denmark, March 4, 2025 /PRNewswire/ -- Siteimprove, the leading AI-powered SaaS-platform for delivering digital content experiences that are compliant and accessible, today announced that Nayaki Nayyar has been appointed Chief Executive Officer (CEO) and Board Member. Nayyar is a seasoned executive with over 25 years of deep industry experience in driving transformation, innovation and growth at large enterprise software comp
INDIANAPOLIS, Oct. 15, 2024 /PRNewswire/ -- Corteva, Inc. (NYSE:CTVA) announced today that it has appointed Judd O'Connor as its new Executive Vice President (EVP) of its Seed Business Unit, effective December 1, 2024. He will succeed Tim Glenn, current Corteva EVP, Seed Business Unit, who will serve as a Strategic Advisor to the executive leadership team until his retirement in the first quarter of 2025, allowing for a seamless transition. O'Connor, a 25-year veteran of Corteva and its heritage companies, assumes this position after serving as the President of its North Amer
YTD results reflect volume gains in both segments, demand for new technology, and outperformance on controllablesCrop Protection YTD results driven by double-digit volume growth in new products and biologicalsSeed YTD results reflect demand for newest hybrids and varieties, strong operational execution, and growth in out-licensingFull-year 2025 guidance3 raised due to year-to-date performance, incremental controllable lever benefits, and strength of growth platformsINDIANAPOLIS, Nov. 4, 2025 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) ("Corteva" or the "Company") today reported financial results for the third quarter and nine months ended September 30, 2025.
INDIANAPOLIS, Oct. 31, 2025 /PRNewswire/ -- Corteva, Inc. (NYSE:CTVA) today announced its Board of Directors has authorized a common stock dividend of $0.18 cents per share, payable December 15, 2025, to the Company's shareholders of record on December 1, 2025. EIDP, Inc. Announces Preferred Stock Dividend The Board of Directors of EIDP, Inc. (formerly known as E. I. du Pont de Nemours and Company) (EIDP) declared regular preferred stock dividends of $1.12-1/2 per share on the $4.50 series preferred stock and $0.87-1/2 per share on the $3.50 series preferred stock – both payab
Separation to give shareholders two compelling investment opportunities New Corteva to be a market leader differentiated by its innovative solutions, including biologicals, and focus on operational excellenceSpinCo to be a leader in advanced genetics and build upon a century-long track record of customer loyalty, elite breeding, market leadership and financial strengthTax-free transaction expected to be completed in the second half of 2026Full-year 2025 guidance reaffirmed; 2027 value framework intactCorteva to host investor call on October 1 at 8:30 AM EDTINDIANAPOLIS, Oct. 1, 2025 /PRNewswire/ -- Global agriculture technology leader Corteva (NYSE:CTVA) announced today that its Board of Dire
SC 13G/A - Corteva, Inc. (0001755672) (Subject)
SC 13G/A - Corteva, Inc. (0001755672) (Subject)
SC 13G/A - Corteva, Inc. (0001755672) (Subject)